HMG-CoA Reductase Inhibitor [EPC]

HMG-CoA Reductase Inhibitor [EPC] was reported 373656 times

Drugs of the HMG-CoA Reductase Inhibitor [EPC] class are most commonly taken among patients reporting these side effects:

# Drug class Count Frequency
0 APPENDICOLITH 311 0.8036
1 CARDIOSPASM 410 0.7348
2 PALMOPLANTAR KERATODERMA 398 0.5490
3 AMAUROSIS FUGAX 287 0.2665
4 ATRIAL TACHYCARDIA 517 0.2460
5 MYOPATHY 2090 0.2417
6 HYPERPARATHYROIDISM SECONDARY 587 0.2341
7 IMMUNE-MEDIATED MYOSITIS 641 0.2323
8 NEPHROGENIC ANAEMIA 1041 0.2245
9 RHABDOMYOLYSIS 8963 0.2147
10 PRURITUS GENITAL 476 0.2020
11 REBOUND ACID HYPERSECRETION 568 0.1876
12 CAROTID ARTERY OCCLUSION 684 0.1873
13 CORONARY ARTERY STENOSIS 680 0.1351
14 BLOOD PRESSURE SYSTOLIC ABNORMAL 334 0.1350
15 BLOOD PRESSURE DIASTOLIC ABNORMAL 335 0.1316
16 BLOOD CREATINE PHOSPHOKINASE INCREASED 3690 0.1280
17 RADICULOPATHY 336 0.1274
18 TENSION HEADACHE 542 0.1259
19 SEDATION COMPLICATION 320 0.1253
20 MYOSITIS 1124 0.1251
21 ISCHAEMIC CARDIOMYOPATHY 381 0.1241
22 CAROTID ARTERY STENOSIS 419 0.1199
23 ANGINA UNSTABLE 763 0.1173
24 ARTERIOSCLEROSIS CORONARY ARTERY 775 0.1169
25 BLOOD PHOSPHORUS INCREASED 319 0.1167
26 DYSLIPIDAEMIA 593 0.1166
27 DIABETIC NEUROPATHY 573 0.1156
28 DIASTOLIC DYSFUNCTION 356 0.1152
29 AORTIC ARTERIOSCLEROSIS 295 0.1145
30 CHRONIC SINUSITIS 429 0.1142
31 END STAGE RENAL DISEASE 2065 0.1131
32 AORTIC STENOSIS 391 0.1122
33 HYPERLIPIDAEMIA 1325 0.1108
34 RALES 643 0.1106
35 HAEMORRHAGIC ANAEMIA 486 0.1105
36 SLEEP TERROR 462 0.1096
37 NORMOCHROMIC NORMOCYTIC ANAEMIA 328 0.1091
38 LEFT VENTRICULAR HYPERTROPHY 463 0.1081
39 ARTERIOSCLEROSIS 989 0.1050
40 CORONARY ARTERY DISEASE 3180 0.1049
41 MUSCLE RUPTURE 408 0.1047
42 CREATININE RENAL CLEARANCE DECREASED 415 0.1036
43 HIGH DENSITY LIPOPROTEIN DECREASED 345 0.1035
44 BENIGN PROSTATIC HYPERPLASIA 517 0.1000
45 BUNDLE BRANCH BLOCK LEFT 420 0.0989
46 RENAL FAILURE ACUTE 4154 0.0978
47 VENTRICULAR HYPOKINESIA 310 0.0964
48 ORTHOPNOEA 306 0.0960
49 MITRAL VALVE INCOMPETENCE 1087 0.0959
50 MACULAR DEGENERATION 1136 0.0950
51 BREATH SOUNDS ABNORMAL 466 0.0944
52 BRONCHIECTASIS 634 0.0940
53 POTENTIATING DRUG INTERACTION 314 0.0935
54 CHRONIC KIDNEY DISEASE 7015 0.0922
55 CORONARY ARTERY OCCLUSION 1252 0.0912
56 RENAL FAILURE CHRONIC 695 0.0903
57 POLYMYALGIA RHEUMATICA 286 0.0899
58 PERIPHERAL ARTERIAL OCCLUSIVE DISEASE 362 0.0886
59 HYPERCHOLESTEROLAEMIA 855 0.0885
60 TYPE 2 DIABETES MELLITUS 2973 0.0882
61 CARDIAC FAILURE CHRONIC 375 0.0879
62 HAEMORRHAGIC STROKE 682 0.0872
63 EXERCISE TOLERANCE DECREASED 501 0.0870
64 MYALGIA 14533 0.0854
65 TRICUSPID VALVE INCOMPETENCE 670 0.0842
66 MYOCARDIAL ISCHAEMIA 953 0.0837
67 PERIPHERAL VASCULAR DISORDER 431 0.0836
68 DIVERTICULUM 590 0.0829
69 AORTIC VALVE INCOMPETENCE 352 0.0826
70 SUPRAVENTRICULAR EXTRASYSTOLES 279 0.0825
71 SUBARACHNOID HAEMORRHAGE 841 0.0825
72 BLOOD CHOLESTEROL ABNORMAL 380 0.0822
73 ATRIOVENTRICULAR BLOCK FIRST DEGREE 356 0.0820
74 ORTHOSTATIC HYPOTENSION 1429 0.0820
75 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 718 0.0811
76 ARTERIAL OCCLUSIVE DISEASE 637 0.0810
77 ANGINA PECTORIS 2315 0.0807
78 ACUTE MYOCARDIAL INFARCTION 2377 0.0805
79 URINARY TRACT DISORDER 360 0.0799
80 EUGLYCAEMIC DIABETIC KETOACIDOSIS 330 0.0798
81 DIVERTICULUM INTESTINAL 349 0.0797
82 BLOOD PRESSURE SYSTOLIC INCREASED 1536 0.0787
83 BLOOD PRESSURE DIASTOLIC DECREASED 579 0.0784
84 UPPER GASTROINTESTINAL HAEMORRHAGE 1312 0.0779
85 FACIAL PAIN 695 0.0778
86 LOW DENSITY LIPOPROTEIN INCREASED 598 0.0772
87 LOWER GASTROINTESTINAL HAEMORRHAGE 571 0.0772
88 IRON DEFICIENCY 347 0.0771
89 SPINAL OSTEOARTHRITIS 676 0.0769
90 BLOOD URIC ACID INCREASED 442 0.0765
91 MUSCLE ATROPHY 962 0.0759
92 VENTRICULAR TACHYCARDIA 1252 0.0757
93 TROPONIN INCREASED 576 0.0756
94 ACUTE CORONARY SYNDROME 627 0.0756
95 MUSCLE DISORDER 610 0.0752
96 TRANSIENT ISCHAEMIC ATTACK 2535 0.0751
97 ACUTE KIDNEY INJURY 11329 0.0740
98 ATRIAL FLUTTER 589 0.0737
99 DIABETES MELLITUS INADEQUATE CONTROL 1306 0.0737
100 DRUG INTERACTION 11703 0.0737
101 RENAL CYST 585 0.0736
102 OBSTRUCTIVE AIRWAYS DISORDER 818 0.0735
103 VENTRICULAR FIBRILLATION 815 0.0733
104 INTERNATIONAL NORMALISED RATIO INCREASED 2068 0.0725
105 HYPERKALAEMIA 2523 0.0719
106 HYPOVOLAEMIA 420 0.0717
107 LEFT VENTRICULAR DYSFUNCTION 478 0.0713
108 BLOOD PRESSURE INADEQUATELY CONTROLLED 429 0.0712
109 BLOOD CHOLESTEROL INCREASED 3315 0.0710
110 IDIOPATHIC PULMONARY FIBROSIS 281 0.0710
111 TENDON RUPTURE 871 0.0705
112 VASCULITIS 820 0.0703
113 CARDIOMEGALY 865 0.0703
114 DYSPNOEA EXERTIONAL 2646 0.0702
115 HIATUS HERNIA 907 0.0700
116 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 354 0.0699
117 INTERNATIONAL NORMALISED RATIO DECREASED 282 0.0696
118 CARDIAC MURMUR 597 0.0689
119 GLOMERULAR FILTRATION RATE DECREASED 844 0.0686
120 ELECTROCARDIOGRAM ABNORMAL 538 0.0685
121 BLOOD UREA INCREASED 1137 0.0678
122 HYPOMAGNESAEMIA 938 0.0673
123 GLUCOSE TOLERANCE IMPAIRED 398 0.0672
124 GASTRITIS EROSIVE 313 0.0671
125 ABNORMAL LOSS OF WEIGHT 456 0.0668
126 RENAL TUBULAR NECROSIS 654 0.0666
127 BUNDLE BRANCH BLOCK RIGHT 303 0.0659
128 CHRONIC LYMPHOCYTIC LEUKAEMIA 312 0.0657
129 BLOOD CALCIUM DECREASED 736 0.0654
130 TUBULOINTERSTITIAL NEPHRITIS 1226 0.0653
131 GOUT 1173 0.0653
132 BLOOD CREATINE INCREASED 289 0.0652
133 UROSEPSIS 600 0.0650
134 RENAL INJURY 1906 0.0641
135 VENTRICULAR EXTRASYSTOLES 664 0.0639
136 NOCTURIA 773 0.0636
137 ATRIOVENTRICULAR BLOCK COMPLETE 426 0.0636
138 MYASTHENIA GRAVIS 514 0.0636
139 CARDIOGENIC SHOCK 908 0.0632
140 DUODENAL ULCER 444 0.0629
141 ATRIAL FIBRILLATION 6125 0.0628
142 AORTIC ANEURYSM 478 0.0628
143 HAEMATURIA 2139 0.0624
144 IRON DEFICIENCY ANAEMIA 576 0.0623
145 LACTIC ACIDOSIS 2014 0.0621
146 BLOOD TRIGLYCERIDES INCREASED 1097 0.0620
147 BLOOD POTASSIUM INCREASED 1007 0.0620
148 FULL BLOOD COUNT ABNORMAL 654 0.0618
149 RENAL FAILURE 8204 0.0617
150 MUSCULAR WEAKNESS 6954 0.0611
151 SLEEP APNOEA SYNDROME 1165 0.0610
152 DIZZINESS POSTURAL 591 0.0609
153 HYPONATRAEMIA 3432 0.0609
154 ATELECTASIS 587 0.0607
155 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 3162 0.0605
156 SEASONAL ALLERGY 848 0.0599
157 ATRIOVENTRICULAR BLOCK 462 0.0597
158 BODY HEIGHT DECREASED 637 0.0595
159 TENDERNESS 618 0.0592
160 SPINAL COLUMN STENOSIS 280 0.0592
161 HAEMATEMESIS 1498 0.0590
162 LIVER FUNCTION TEST ABNORMAL 1718 0.0590
163 AUTOIMMUNE HEPATITIS 408 0.0586
164 SINUS BRADYCARDIA 563 0.0582
165 HYPOGLYCAEMIA 2820 0.0581
166 BLOOD PRESSURE FLUCTUATION 1391 0.0579
167 ANURIA 498 0.0578
168 PULMONARY FIBROSIS 1108 0.0577
169 DIPLOPIA 1500 0.0577
170 BLOOD CALCIUM INCREASED 505 0.0575
171 RHINITIS 462 0.0572
172 SKIN LACERATION 622 0.0571
173 STENT PLACEMENT 461 0.0571
174 PANCREATITIS ACUTE 1284 0.0571
175 MELAENA 1257 0.0571
176 INTERVERTEBRAL DISC DEGENERATION 528 0.0570
177 OCULAR DISCOMFORT 639 0.0569
178 HYPERGLYCAEMIA 2047 0.0561
179 IMPAIRED GASTRIC EMPTYING 764 0.0560
180 MICTURITION URGENCY 638 0.0558
181 GINGIVAL PAIN 442 0.0555
182 PSYCHIATRIC SYMPTOM 409 0.0554
183 BLOOD CREATININE INCREASED 3606 0.0552
184 ANGIOPATHY 309 0.0551
185 EXTRASYSTOLES 384 0.0550
186 SPUTUM DISCOLOURED 521 0.0549
187 CHROMATURIA 1238 0.0548
188 BLOOD MAGNESIUM DECREASED 473 0.0548
189 CEREBRAL ISCHAEMIA 282 0.0547
190 HAEMODIALYSIS 460 0.0547
191 EJECTION FRACTION DECREASED 851 0.0547
192 SUBDURAL HAEMATOMA 781 0.0545
193 OESOPHAGITIS 596 0.0545
194 HEPATIC STEATOSIS 1016 0.0545
195 HEMIPARESIS 922 0.0544
196 CARDIAC FAILURE ACUTE 362 0.0543
197 BODY TEMPERATURE DECREASED 534 0.0542
198 POLYP 355 0.0542
199 HAEMATOCRIT DECREASED 1073 0.0541
200 CIRCULATORY COLLAPSE 921 0.0540
201 GASTROINTESTINAL HAEMORRHAGE 4516 0.0540
202 GROIN PAIN 474 0.0539
203 GANGRENE 323 0.0535
204 OSTEOARTHRITIS 2271 0.0535
205 OEDEMA PERIPHERAL 6490 0.0532
206 PRESYNCOPE 1293 0.0531
207 ECCHYMOSIS 364 0.0530
208 LARGE INTESTINE POLYP 367 0.0529
209 APPENDICITIS 494 0.0528
210 RECTAL HAEMORRHAGE 2272 0.0528
211 BLOOD URINE PRESENT 1003 0.0528
212 PROTHROMBIN TIME PROLONGED 315 0.0526
213 CARDIAC VALVE DISEASE 299 0.0523
214 CARDIAC FAILURE CONGESTIVE 4184 0.0520
215 SYNCOPE 5210 0.0520
216 FAECALOMA 285 0.0520
217 ISCHAEMIC STROKE 925 0.0518
218 ELECTROLYTE IMBALANCE 602 0.0518
219 HEMIPLEGIA 431 0.0518
220 BLOOD ALBUMIN DECREASED 411 0.0518
221 HAEMOPTYSIS 1442 0.0516
222 FLANK PAIN 484 0.0516
223 HEPATITIS CHOLESTATIC 311 0.0516
224 VITAMIN D DEFICIENCY 503 0.0515
225 BALANCE DISORDER 4451 0.0514
226 BASAL CELL CARCINOMA 801 0.0513
227 HAIR DISORDER 423 0.0513
228 ROTATOR CUFF SYNDROME 659 0.0513
229 PRODUCTIVE COUGH 2445 0.0512
230 CORONARY ARTERY BYPASS 294 0.0511
231 INCREASED TENDENCY TO BRUISE 470 0.0510
232 HYPOPHOSPHATAEMIA 377 0.0510
233 POLYURIA 416 0.0508
234 PEMPHIGOID 382 0.0506
235 NEPHROPATHY 470 0.0503
236 ORAL CANDIDIASIS 660 0.0501
237 GASTROOESOPHAGEAL REFLUX DISEASE 4012 0.0498
238 GASTRITIS 1311 0.0498
239 BLOOD SODIUM DECREASED 939 0.0498
240 BRADYCARDIA 2639 0.0497
241 PSYCHOLOGICAL TRAUMA 429 0.0497
242 CARPAL TUNNEL SYNDROME 696 0.0496
243 HYPOKALAEMIA 2288 0.0495
244 EMPHYSEMA 499 0.0494
245 HEART RATE DECREASED 1734 0.0493
246 DIABETES MELLITUS 3740 0.0490
247 CHEST PAIN 9010 0.0486
248 DEHYDRATION 6478 0.0485
249 TINNITUS 2227 0.0484
250 FAECES DISCOLOURED 1044 0.0481
251 LIPASE INCREASED 368 0.0480
252 EXOSTOSIS 438 0.0479
253 MIDDLE INSOMNIA 895 0.0479
254 NEUTROPENIC SEPSIS 342 0.0478
255 ANOSMIA 693 0.0478
256 SENSORY LOSS 385 0.0478
257 MULTIPLE INJURIES 300 0.0476
258 VITAMIN D DECREASED 406 0.0474
259 FALL 15793 0.0474
260 MYOCARDIAL INFARCTION 8270 0.0474
261 PULMONARY HYPERTENSION 987 0.0473
262 HAEMATOCHEZIA 2604 0.0471
263 QUALITY OF LIFE DECREASED 633 0.0471
264 GENERALISED OEDEMA 583 0.0471
265 INFARCTION 322 0.0470
266 CARDIAC PACEMAKER INSERTION 280 0.0469
267 LIP SWELLING 1564 0.0469
268 HAEMATOMA 1215 0.0468
269 COGNITIVE DISORDER 2188 0.0468
270 HEART RATE IRREGULAR 1057 0.0467
271 ACUTE RESPIRATORY FAILURE 899 0.0467
272 OBESITY 744 0.0467
273 LUNG INFILTRATION 412 0.0466
274 RENAL IMPAIRMENT 3914 0.0465
275 HYPERTENSIVE CRISIS 518 0.0465
276 PAROSMIA 351 0.0465
277 AMNESIA 3017 0.0463
278 WHEEZING 2748 0.0463
279 BLOOD IRON DECREASED 548 0.0461
280 GASTRIC ULCER 877 0.0461
281 COLITIS ISCHAEMIC 311 0.0461
282 INITIAL INSOMNIA 473 0.0461
283 FLUSHING 4686 0.0461
284 ACIDOSIS 351 0.0459
285 HAIR COLOUR CHANGES 571 0.0458
286 DYSURIA 1685 0.0457
287 GLYCOSYLATED HAEMOGLOBIN INCREASED 1154 0.0457
288 BLOOD GLUCOSE FLUCTUATION 501 0.0457
289 MUSCLE TWITCHING 1053 0.0456
290 POLLAKIURIA 1904 0.0456
291 URINE OUTPUT DECREASED 399 0.0456
292 METABOLIC ACIDOSIS 1458 0.0455
293 EYE PAIN 2570 0.0455
294 HEAD DISCOMFORT 805 0.0454
295 HYPOTENSION 9115 0.0454
296 MUSCLE SPASMS 8336 0.0454
297 PULMONARY MASS 676 0.0453
298 INFUSION SITE ERYTHEMA 382 0.0453
299 COORDINATION ABNORMAL 630 0.0451
300 BLOOD POTASSIUM DECREASED 1354 0.0450
301 URINARY INCONTINENCE 1334 0.0450
302 CLOSTRIDIUM DIFFICILE COLITIS 477 0.0449
303 INFUSION SITE SWELLING 283 0.0449
304 TENDONITIS 696 0.0449
305 ECONOMIC PROBLEM 681 0.0449
306 SUPRAVENTRICULAR TACHYCARDIA 430 0.0449
307 WALKING AID USER 296 0.0448
308 MUSCULOSKELETAL PAIN 2348 0.0448
309 HAEMORRHOIDS 874 0.0448
310 SCIATICA 712 0.0446
311 COAGULOPATHY 744 0.0446
312 PULMONARY CONGESTION 588 0.0446
313 OEDEMA 2417 0.0445
314 ERECTILE DYSFUNCTION 1144 0.0445
315 JOINT EFFUSION 307 0.0445
316 CONFUSIONAL STATE 7188 0.0444
317 DIVERTICULITIS 1232 0.0444
318 MUSCULOSKELETAL DISCOMFORT 762 0.0442
319 CARDIOMYOPATHY 654 0.0442
320 CATARACT 2633 0.0442
321 OXYGEN SATURATION DECREASED 2480 0.0441
322 NEUTROPHIL COUNT INCREASED 451 0.0440
323 SINUS CONGESTION 595 0.0440
324 SWOLLEN TONGUE 1375 0.0440
325 INTERVERTEBRAL DISC PROTRUSION 962 0.0440
326 HYPOKINESIA 637 0.0438
327 CONSTIPATION 9566 0.0438
328 ASTHENIA 16492 0.0438
329 POLYNEUROPATHY 525 0.0438
330 PARAESTHESIA ORAL 632 0.0438
331 PULMONARY OEDEMA 1959 0.0437
332 ANAL INCONTINENCE 393 0.0436
333 OSTEOPENIA 660 0.0434
334 CARDIAC FAILURE 3491 0.0434
335 GAMMA-GLUTAMYLTRANSFERASE INCREASED 962 0.0434
336 BLOOD PRESSURE INCREASED 6634 0.0433
337 ALANINE AMINOTRANSFERASE INCREASED 2658 0.0432
338 PAIN IN EXTREMITY 12709 0.0431
339 MULTI-ORGAN FAILURE 744 0.0430
340 HAEMOGLOBIN DECREASED 4401 0.0428
341 TRANSAMINASES INCREASED 951 0.0427
342 ASCITES 1255 0.0426
343 RESPIRATORY RATE INCREASED 379 0.0426
344 DYSARTHRIA 1606 0.0426
345 NEURALGIA 1036 0.0426
346 UPPER-AIRWAY COUGH SYNDROME 351 0.0426
347 ACTIVITIES OF DAILY LIVING IMPAIRED 842 0.0425
348 NIGHTMARE 1469 0.0424
349 SKIN ULCER 1096 0.0424
350 ABASIA 1047 0.0423
351 HYPOXIA 1492 0.0423
352 HAIR TEXTURE ABNORMAL 566 0.0423
353 ANAEMIA 8061 0.0422
354 EPISTAXIS 3161 0.0422
355 BLOOD ALKALINE PHOSPHATASE INCREASED 1049 0.0422
356 HEAD INJURY 1336 0.0422
357 MUSCLE STRAIN 365 0.0421
358 BLOOD TESTOSTERONE DECREASED 288 0.0421
359 ARTHRITIS 3302 0.0419
360 RESPIRATORY TRACT INFECTION 1088 0.0417
361 SQUAMOUS CELL CARCINOMA 393 0.0417
362 PROSTATIC SPECIFIC ANTIGEN INCREASED 575 0.0417
363 ANGIOEDEMA 1845 0.0417
364 HYPOPHAGIA 1066 0.0417
365 HAEMORRHAGE INTRACRANIAL 623 0.0416
366 CHOLELITHIASIS 1366 0.0416
367 URINARY RETENTION 1389 0.0416
368 APHASIA 1257 0.0416
369 DYSPEPSIA 4093 0.0416
370 DIABETIC KETOACIDOSIS 999 0.0415
371 SINUS DISORDER 822 0.0415
372 ASPARTATE AMINOTRANSFERASE INCREASED 2204 0.0414
373 BURSITIS 502 0.0413
374 GENERAL PHYSICAL HEALTH DETERIORATION 4773 0.0412
375 CYSTITIS 1311 0.0411
376 CONTUSION 3963 0.0411
377 HALLUCINATION, VISUAL 869 0.0411
378 GAIT DISTURBANCE 7876 0.0411
379 RED BLOOD CELL SEDIMENTATION RATE INCREASED 455 0.0411
380 COUGH 11525 0.0411
381 RESTLESS LEGS SYNDROME 745 0.0409
382 ARRHYTHMIA 1938 0.0409
383 PLEURAL EFFUSION 2489 0.0409
384 RED BLOOD CELL COUNT DECREASED 1167 0.0408
385 CELLULITIS 2056 0.0408
386 NERVE COMPRESSION 376 0.0407
387 INCONTINENCE 430 0.0406
388 DYSPNOEA 23021 0.0406
389 SHOCK HAEMORRHAGIC 331 0.0406
390 HYPERTENSION 8598 0.0405
391 LEUKOCYTOSIS 733 0.0405
392 RIB FRACTURE 833 0.0405
393 PERIPHERAL COLDNESS 556 0.0405
394 WEIGHT DECREASED 11298 0.0404
395 URINARY TRACT INFECTION 6887 0.0403
396 WHITE BLOOD CELL COUNT INCREASED 1549 0.0403
397 JOINT INJURY 862 0.0403
398 AGEUSIA 1003 0.0402
399 GASTROENTERITIS 586 0.0401
400 NODULE 524 0.0401
401 BLOOD PRESSURE ABNORMAL 798 0.0401
402 LIMB INJURY 1090 0.0401
403 DECUBITUS ULCER 327 0.0401
404 INFUSION SITE PAIN 517 0.0401
405 HYPERCALCAEMIA 494 0.0400
406 CONTRAINDICATED PRODUCT ADMINISTERED 1211 0.0400
407 FLATULENCE 2268 0.0400
408 DYSSTASIA 1167 0.0399
409 SKIN HAEMORRHAGE 592 0.0399
410 MOTOR DYSFUNCTION 407 0.0399
411 ANOREXIA 514 0.0398
412 PLATELET COUNT INCREASED 520 0.0398
413 ULCER 633 0.0397
414 MUSCULOSKELETAL CHEST PAIN 615 0.0397
415 EYE HAEMORRHAGE 530 0.0397
416 PURPURA 351 0.0396
417 BLOOD PRESSURE DECREASED 2632 0.0396
418 SECRETION DISCHARGE 496 0.0396
419 NECK PAIN 2213 0.0396
420 MOBILITY DECREASED 2842 0.0395
421 MOUTH HAEMORRHAGE 290 0.0395
422 CEREBROVASCULAR ACCIDENT 6686 0.0394
423 PERIPHERAL SWELLING 6070 0.0394
424 LETHARGY 2266 0.0393
425 OSTEOPOROSIS 1619 0.0393
426 PHOTOPHOBIA 740 0.0393
427 DRY MOUTH 3191 0.0393
428 IMPAIRED QUALITY OF LIFE 564 0.0392
429 PERICARDITIS 659 0.0392
430 FREQUENT BOWEL MOVEMENTS 1059 0.0392
431 CEREBRAL HAEMORRHAGE 1403 0.0391
432 RESPIRATORY TRACT CONGESTION 621 0.0390
433 BLOOD TEST ABNORMAL 549 0.0390
434 DIZZINESS 19465 0.0390
435 TENDON PAIN 295 0.0389
436 ORAL PAIN 869 0.0388
437 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 398 0.0387
438 PANCREATITIS 2045 0.0387
439 BACK PAIN 8984 0.0386
440 DIALYSIS 548 0.0386
441 HYDRONEPHROSIS 289 0.0386
442 HOT FLUSH 2906 0.0385
443 RASH PAPULAR 864 0.0385
444 BRONCHITIS 2853 0.0385
445 HALLUCINATION 2904 0.0385
446 JOINT DISLOCATION 407 0.0385
447 PERICARDIAL EFFUSION 889 0.0384
448 PETECHIAE 401 0.0384
449 GLAUCOMA 740 0.0384
450 DYSPHONIA 2247 0.0384
451 TORSADE DE POINTES 301 0.0383
452 BLADDER DISORDER 380 0.0382
453 ASPIRATION 418 0.0381
454 POST PROCEDURAL HAEMORRHAGE 443 0.0380
455 SEPSIS 4244 0.0380
456 C-REACTIVE PROTEIN INCREASED 1383 0.0380
457 DECREASED APPETITE 8824 0.0380
458 MULTIPLE ALLERGIES 296 0.0377
459 UNRESPONSIVE TO STIMULI 974 0.0377
460 DRUG-INDUCED LIVER INJURY 1184 0.0377
461 ATAXIA 447 0.0376
462 MUSCLE INJURY 312 0.0376
463 CEREBRAL INFARCTION 917 0.0375
464 TOOTH ABSCESS 382 0.0375
465 PALPITATIONS 4392 0.0375
466 MOVEMENT DISORDER 1202 0.0374
467 ABNORMAL DREAMS 1030 0.0373
468 TOOTH FRACTURE 411 0.0372
469 ERUCTATION 721 0.0372
470 BLINDNESS 1518 0.0372
471 LIMB DISCOMFORT 1148 0.0371
472 DECREASED ACTIVITY 400 0.0370
473 CHEST DISCOMFORT 3794 0.0370
474 DISORIENTATION 1466 0.0370
475 BONE DISORDER 673 0.0369
476 BACK DISORDER 600 0.0369
477 FEELING HOT 2262 0.0369
478 MENTAL STATUS CHANGES 1024 0.0368
479 HOSPICE CARE 363 0.0367
480 WRIST FRACTURE 440 0.0367
481 BLOOD GLUCOSE INCREASED 6905 0.0366
482 HYPOTHYROIDISM 1170 0.0366
483 HYPERHIDROSIS 4716 0.0366
484 CHOLECYSTITIS 433 0.0363
485 FOOT DEFORMITY 402 0.0362
486 LOCALISED INFECTION 877 0.0362
487 SLEEP DISORDER 2553 0.0361
488 DEMENTIA 1009 0.0361
489 COLD SWEAT 636 0.0360
490 DELIRIUM 1251 0.0360
491 HEPATITIS 922 0.0360
492 BLOOD COUNT ABNORMAL 546 0.0360
493 PELVIC FRACTURE 280 0.0359
494 ABDOMINAL DISTENSION 3753 0.0359
495 SPINAL PAIN 421 0.0359
496 PNEUMONIA 11619 0.0359
497 DYSGEUSIA 2664 0.0358
498 MALNUTRITION 401 0.0358
499 THYROID DISORDER 552 0.0358
500 SPINAL COMPRESSION FRACTURE 296 0.0358
501 PALLOR 974 0.0358
502 UPPER RESPIRATORY TRACT INFECTION 1651 0.0357
503 HYPOCALCAEMIA 676 0.0357
504 LACRIMATION INCREASED 1079 0.0357
505 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 1715 0.0357
506 PRODUCT PRESCRIBING ERROR 850 0.0356
507 HEPATOMEGALY 350 0.0356
508 DISTURBANCE IN ATTENTION 1919 0.0355
509 POOR QUALITY SLEEP 765 0.0355
510 HYPERSOMNIA 1018 0.0355
511 HEART RATE INCREASED 3517 0.0355
512 ARTHRALGIA 14733 0.0354
513 VERTIGO 2158 0.0354
514 BLOOD GLUCOSE ABNORMAL 653 0.0353
515 MADAROSIS 410 0.0353
516 RETCHING 753 0.0353
517 JAUNDICE 950 0.0353
518 DRUG LEVEL INCREASED 584 0.0352
519 PROTEINURIA 668 0.0351
520 EYE PRURITUS 1180 0.0351
521 RHINORRHOEA 2267 0.0350
522 DIARRHOEA 22639 0.0350
523 HIP FRACTURE 1127 0.0350
524 RESPIRATORY FAILURE 2554 0.0350
525 CARDIAC DISORDER 3272 0.0349
526 SKIN LESION 958 0.0349
527 WEIGHT FLUCTUATION 365 0.0349
528 EATING DISORDER 741 0.0348
529 LACERATION 327 0.0347
530 LOWER RESPIRATORY TRACT INFECTION 1578 0.0347
531 ASTHMA 3921 0.0347
532 NEUROPATHY PERIPHERAL 3299 0.0346
533 ABDOMINAL PAIN UPPER 7136 0.0346
534 INTERNAL HAEMORRHAGE 396 0.0346
535 SINUS TACHYCARDIA 492 0.0346
536 TOOTH INFECTION 456 0.0346
537 ELECTROCARDIOGRAM QT PROLONGED 1241 0.0345
538 RENAL DISORDER 1606 0.0344
539 PHOTOSENSITIVITY REACTION 569 0.0344
540 TACHYCARDIA 3060 0.0344
541 MEMORY IMPAIRMENT 4717 0.0343
542 ABDOMINAL DISCOMFORT 5756 0.0343
543 ESCHERICHIA INFECTION 282 0.0342
544 ANKLE FRACTURE 530 0.0342
545 MUSCULOSKELETAL STIFFNESS 2998 0.0342
546 INSOMNIA 9099 0.0341
547 HYPERTHYROIDISM 494 0.0341
548 FATIGUE 26565 0.0341
549 FEAR 917 0.0341
550 EAR PAIN 662 0.0340
551 DRY THROAT 346 0.0340
552 FOOT FRACTURE 644 0.0339
553 BLOOD GLUCOSE DECREASED 1631 0.0339
554 PARAESTHESIA 5332 0.0339
555 ANHEDONIA 890 0.0338
556 IMPAIRED WORK ABILITY 723 0.0338
557 LOCAL SWELLING 589 0.0337
558 DYSPHAGIA 3200 0.0337
559 COLITIS 1278 0.0337
560 ABDOMINAL PAIN 7834 0.0336
561 GAIT INABILITY 1125 0.0336
562 LOSS OF CONSCIOUSNESS 4309 0.0336
563 FLUID RETENTION 1710 0.0336
564 EOSINOPHILIA 584 0.0333
565 BEDRIDDEN 438 0.0333
566 MALIGNANT MELANOMA 446 0.0333
567 RETINAL DETACHMENT 306 0.0333
568 CHOLESTASIS 637 0.0331
569 RASH PRURITIC 1797 0.0331
570 TRANSFUSION 347 0.0331
571 FEELING COLD 922 0.0331
572 TASTE DISORDER 671 0.0330
573 VITREOUS FLOATERS 325 0.0330
574 NEPHROLITHIASIS 1516 0.0330
575 FACIAL PARALYSIS 281 0.0329
576 FULL BLOOD COUNT DECREASED 664 0.0329
577 GASTROINTESTINAL PAIN 362 0.0329
578 BACTERIAL INFECTION 612 0.0328
579 HYPOTHERMIA 331 0.0327
580 ARTHROPATHY 1817 0.0327
581 PAIN IN JAW 926 0.0327
582 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 554 0.0326
583 BLOOD THYROID STIMULATING HORMONE INCREASED 300 0.0326
584 SNEEZING 731 0.0326
585 MULTIPLE ORGAN DYSFUNCTION SYNDROME 923 0.0326
586 JOINT STIFFNESS 854 0.0325
587 HEPATIC ENZYME INCREASED 2213 0.0324
588 PRURITUS GENERALISED 702 0.0324
589 CARDIO-RESPIRATORY ARREST 1355 0.0324
590 POST PROCEDURAL COMPLICATION 622 0.0324
591 PULMONARY EMBOLISM 3060 0.0322
592 PNEUMONIA ASPIRATION 804 0.0321
593 SINUSITIS 3297 0.0321
594 RENAL PAIN 340 0.0320
595 SPEECH DISORDER 1678 0.0320
596 SCAB 365 0.0320
597 SPINAL DISORDER 303 0.0320
598 SKIN DISCOLOURATION 1469 0.0319
599 KIDNEY INFECTION 627 0.0319
600 BURNING SENSATION 2240 0.0319
601 THROMBOSIS 2569 0.0319
602 NASAL CONGESTION 1876 0.0319
603 PERSONALITY CHANGE 296 0.0318
604 SUDDEN DEATH 337 0.0318
605 JOINT SWELLING 3843 0.0318
606 ILEUS 395 0.0318
607 PARALYSIS 454 0.0317
608 HERNIA 613 0.0317
609 OROPHARYNGEAL PAIN 2932 0.0316
610 BODY TEMPERATURE INCREASED 645 0.0316
611 DEEP VEIN THROMBOSIS 2052 0.0315
612 FLUID OVERLOAD 459 0.0315
613 COVID-19 PNEUMONIA 372 0.0315
614 PARKINSONISM 307 0.0315
615 MUSCLE RIGIDITY 376 0.0314
616 DEPRESSION 7149 0.0314
617 CARDIOVASCULAR DISORDER 797 0.0314
618 TREMOR 5199 0.0313
619 LUNG DISORDER 1535 0.0313
620 EYE INFECTION 353 0.0312
621 TOXIC EPIDERMAL NECROLYSIS 474 0.0312
622 NERVE INJURY 347 0.0312
623 HYPOAESTHESIA 4671 0.0312
624 MYOCLONUS 372 0.0312
625 JOINT RANGE OF MOTION DECREASED 418 0.0311
626 BLOOD BILIRUBIN INCREASED 840 0.0311
627 SPLENOMEGALY 364 0.0310
628 ABDOMINAL PAIN LOWER 785 0.0310
629 VISION BLURRED 4262 0.0310
630 EAR DISCOMFORT 318 0.0310
631 VOMITING 14551 0.0309
632 SCRATCH 326 0.0309
633 DRUG INTOLERANCE 2985 0.0309
634 OSTEOMYELITIS 559 0.0308
635 UPPER LIMB FRACTURE 615 0.0308
636 MALAISE 13532 0.0308
637 HYPOTONIA 308 0.0308
638 WOUND 862 0.0308
639 CARDIAC ARREST 2541 0.0307
640 GINGIVAL BLEEDING 420 0.0307
641 BACK INJURY 334 0.0307
642 BLOOD LACTATE DEHYDROGENASE INCREASED 486 0.0306
643 DEPRESSED LEVEL OF CONSCIOUSNESS 1212 0.0306
644 SMALL INTESTINAL OBSTRUCTION 377 0.0306
645 BLINDNESS UNILATERAL 432 0.0306
646 THROAT IRRITATION 1371 0.0305
647 SOMNOLENCE 6149 0.0305
648 SENSORY DISTURBANCE 490 0.0305
649 CHILLS 3576 0.0305
650 ALTERED STATE OF CONSCIOUSNESS 660 0.0304
651 FIBROMYALGIA 740 0.0304
652 RESPIRATORY DISTRESS 840 0.0304
653 TOOTHACHE 551 0.0304
654 MUSCLE TIGHTNESS 493 0.0304
655 DELUSION 472 0.0304
656 NIGHT SWEATS 979 0.0304
657 CLOSTRIDIUM DIFFICILE INFECTION 663 0.0303
658 PAIN OF SKIN 814 0.0302
659 NAUSEA 23887 0.0302
660 DERMATITIS CONTACT 344 0.0301
661 SWELLING FACE 1962 0.0301
662 DEPRESSED MOOD 1592 0.0301
663 DRUG ERUPTION 531 0.0299
664 DIARRHOEA HAEMORRHAGIC 280 0.0299
665 LIVER INJURY 735 0.0299
666 CHOKING 584 0.0299
667 MASS 418 0.0299
668 RASH MACULAR 1045 0.0299
669 PHARYNGEAL OEDEMA 459 0.0298
670 LIGAMENT SPRAIN 295 0.0298
671 PRURITUS 11448 0.0298
672 EYE SWELLING 1108 0.0298
673 LIVER FUNCTION TEST INCREASED 639 0.0297
674 SHOCK 683 0.0297
675 VISUAL ACUITY REDUCED 985 0.0296
676 APHONIA 413 0.0296
677 HYPOAESTHESIA ORAL 445 0.0295
678 PLATELET COUNT DECREASED 3144 0.0295
679 SKIN CANCER 634 0.0294
680 SLUGGISHNESS 300 0.0294
681 NERVOUSNESS 1532 0.0293
682 SALIVARY HYPERSECRETION 290 0.0290
683 MEDICATION ERROR 1611 0.0290
684 DENTAL CARIES 320 0.0289
685 DYSKINESIA 1175 0.0289
686 IMPAIRED HEALING 949 0.0289
687 VISUAL IMPAIRMENT 3581 0.0289
688 FEELING JITTERY 550 0.0288
689 PHARYNGITIS 358 0.0288
690 DEAFNESS 753 0.0288
691 GALLBLADDER DISORDER 514 0.0288
692 GASTRIC HAEMORRHAGE 331 0.0287
693 TOOTH DISORDER 639 0.0287
694 BLISTER 1613 0.0287
695 RESTLESSNESS 1051 0.0287
696 FEELING ABNORMAL 6877 0.0287
697 HERPES ZOSTER 1646 0.0286
698 EYELID PTOSIS 291 0.0286
699 PULMONARY THROMBOSIS 312 0.0286
700 INTERSTITIAL LUNG DISEASE 1385 0.0286
701 SPINAL FRACTURE 572 0.0285
702 HEPATOTOXICITY 635 0.0285
703 EYE DISCHARGE 296 0.0285
704 EYE IRRITATION 1636 0.0284
705 PAIN 17444 0.0284
706 FEMUR FRACTURE 879 0.0284
707 KNEE ARTHROPLASTY 597 0.0283
708 ANXIETY 8067 0.0283
709 TACHYPNOEA 385 0.0283
710 PRESCRIBED UNDERDOSE 563 0.0282
711 PNEUMONITIS 767 0.0281
712 BACTERAEMIA 333 0.0280
713 INFLUENZA 3123 0.0280
714 COVID-19 4913 0.0280
715 GASTRIC DISORDER 959 0.0279
716 SEDATION 730 0.0278
717 BREAST PAIN 297 0.0278
718 STAPHYLOCOCCAL INFECTION 916 0.0277
719 WOUND INFECTION 304 0.0277
720 WEIGHT INCREASED 6216 0.0277
721 HEADACHE 17400 0.0277
722 CYST 344 0.0277
723 THIRST 494 0.0276
724 SWELLING 2586 0.0276
725 IMPAIRED DRIVING ABILITY 313 0.0275
726 VAGINAL DISCHARGE 278 0.0274
727 BRAIN FOG 430 0.0274
728 ORAL DISCOMFORT 381 0.0274
729 DRUG PRESCRIBING ERROR 526 0.0273
730 SEROTONIN SYNDROME 525 0.0273
731 SKIN INFECTION 306 0.0273
732 INTENTIONAL PRODUCT USE ISSUE 2373 0.0271
733 MUSCLE SPASTICITY 332 0.0270
734 RASH GENERALISED 698 0.0269
735 MUSCULOSKELETAL DISORDER 513 0.0269
736 SEPTIC SHOCK 1172 0.0269
737 RASH ERYTHEMATOUS 1287 0.0269
738 PANCYTOPENIA 1504 0.0269
739 LABORATORY TEST ABNORMAL 793 0.0268
740 MOUTH ULCERATION 565 0.0268
741 NASOPHARYNGITIS 4923 0.0267
742 BONE PAIN 1561 0.0266
743 GASTROENTERITIS VIRAL 481 0.0266
744 INTENTIONAL PRODUCT MISUSE 2331 0.0266
745 INFLAMMATION 1367 0.0265
746 LIVER DISORDER 1174 0.0264
747 HEPATOCELLULAR INJURY 374 0.0264
748 HEPATIC CYTOLYSIS 336 0.0263
749 HYPOACUSIS 1134 0.0263
750 TREATMENT NONCOMPLIANCE 1439 0.0263
751 VIRAL INFECTION 875 0.0263
752 PYREXIA 9064 0.0262
753 LYMPHADENOPATHY 927 0.0262
754 HEPATIC CIRRHOSIS 492 0.0262
755 INTRAOCULAR PRESSURE INCREASED 334 0.0261
756 SKIN FISSURES 510 0.0261
757 LUNG INFECTION 405 0.0260
758 DRY EYE 1301 0.0260
759 FUNGAL INFECTION 868 0.0260
760 DERMATITIS ALLERGIC 327 0.0260
761 THROMBOCYTOPENIA 2905 0.0260
762 RASH MACULO-PAPULAR 577 0.0259
763 LYMPHOCYTE COUNT DECREASED 458 0.0259
764 MENTAL IMPAIRMENT 626 0.0258
765 PROCEDURAL PAIN 716 0.0258
766 INJECTION SITE NODULE 284 0.0258
767 IRRITABLE BOWEL SYNDROME 553 0.0258
768 OCULAR HYPERAEMIA 1221 0.0257
769 SKIN DISORDER 856 0.0256
770 ACUTE RESPIRATORY DISTRESS SYNDROME 451 0.0255
771 ACUTE HEPATIC FAILURE 348 0.0254
772 EYELID OEDEMA 296 0.0254
773 PARANOIA 436 0.0253
774 APATHY 368 0.0252
775 ALOPECIA 4951 0.0252
776 DISEASE RECURRENCE 1197 0.0251
777 AGITATION 1848 0.0251
778 CONDITION AGGRAVATED 7634 0.0251
779 EYE DISORDER 825 0.0251
780 FEBRILE NEUTROPENIA 1662 0.0250
781 WHITE BLOOD CELL COUNT DECREASED 2709 0.0250
782 TOOTH EXTRACTION 310 0.0249
783 SCAR 426 0.0249
784 MYELODYSPLASTIC SYNDROME 359 0.0248
785 COLITIS ULCERATIVE 1108 0.0248
786 THROAT TIGHTNESS 668 0.0247
787 ENCEPHALOPATHY 605 0.0246
788 COLON CANCER 366 0.0245
789 HEPATIC FAILURE 738 0.0245
790 NEOPLASM 281 0.0244
791 PULMONARY ARTERIAL HYPERTENSION 354 0.0244
792 STOMATITIS 1472 0.0242
793 CANDIDA INFECTION 408 0.0241
794 FEEDING DISORDER 489 0.0241
795 RESPIRATORY DISORDER 721 0.0241
796 BRONCHOSPASM 343 0.0240
797 HIP ARTHROPLASTY 368 0.0240
798 EAR INFECTION 639 0.0240
799 SKIN EXFOLIATION 2023 0.0240
800 ERYTHEMA 4911 0.0239
801 GASTROINTESTINAL DISORDER 2137 0.0238
802 CONVULSION 1364 0.0238
803 INTESTINAL OBSTRUCTION 898 0.0238
804 WRONG TECHNIQUE IN DRUG USAGE PROCESS 864 0.0238
805 DRUG TOXICITY 323 0.0237
806 PANIC ATTACK 861 0.0236
807 SPINAL OPERATION 291 0.0236
808 INJURY 1660 0.0236
809 THINKING ABNORMAL 440 0.0236
810 INFLUENZA LIKE ILLNESS 1942 0.0236
811 LOWER LIMB FRACTURE 453 0.0236
812 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 1677 0.0236
813 ROAD TRAFFIC ACCIDENT 983 0.0235
814 UNEVALUABLE EVENT 1774 0.0234
815 RASH 10178 0.0233
816 IMMUNODEFICIENCY 348 0.0233
817 INTENTIONAL DOSE OMISSION 664 0.0233
818 METASTASES TO LIVER 409 0.0232
819 ECZEMA 1217 0.0232
820 PRODUCT ADMINISTRATION ERROR 469 0.0232
821 INSURANCE ISSUE 354 0.0231
822 PNEUMOTHORAX 365 0.0230
823 DISCOMFORT 1403 0.0230
824 DERMATITIS 481 0.0229
825 FACE OEDEMA 387 0.0229
826 HAEMORRHAGE 2387 0.0228
827 NO THERAPEUTIC RESPONSE 278 0.0228
828 ACCIDENTAL OVERDOSE 833 0.0227
829 MIGRAINE 2165 0.0227
830 PRODUCT TASTE ABNORMAL 305 0.0225
831 AGGRESSION 1126 0.0225
832 PRODUCT DOSE OMISSION IN ERROR 634 0.0224
833 COMA 1065 0.0223
834 ORAL HERPES 435 0.0223
835 CYANOSIS 350 0.0222
836 INCREASED APPETITE 425 0.0222
837 FRACTURE 418 0.0221
838 PRODUCT SUBSTITUTION ISSUE 1265 0.0219
839 SARS-COV-2 TEST POSITIVE 290 0.0219
840 PSORIASIS 2850 0.0218
841 INFUSION RELATED REACTION 1443 0.0217
842 HUNGER 303 0.0217
843 DISSEMINATED INTRAVASCULAR COAGULATION 305 0.0216
844 PRESCRIBED OVERDOSE 418 0.0216
845 MENTAL DISORDER 940 0.0216
846 DRY SKIN 2878 0.0215
847 ABSCESS 342 0.0214
848 METASTASES TO BONE 351 0.0214
849 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 364 0.0212
850 PHARMACEUTICAL PRODUCT COMPLAINT 550 0.0212
851 HYPERSENSITIVITY 3926 0.0211
852 OSTEONECROSIS OF JAW 522 0.0211
853 HALLUCINATION, AUDITORY 334 0.0210
854 INFECTION 3036 0.0210
855 RHEUMATOID ARTHRITIS 2381 0.0209
856 GLOSSODYNIA 466 0.0208
857 LEUKOPENIA 1040 0.0208
858 ILLNESS 2136 0.0207
859 PSORIATIC ARTHROPATHY 840 0.0207
860 CONJUNCTIVITIS 382 0.0206
861 THERAPEUTIC RESPONSE UNEXPECTED 918 0.0204
862 HEPATIC FUNCTION ABNORMAL 761 0.0204
863 LYMPHOMA 315 0.0204
864 MOOD ALTERED 554 0.0203
865 STEVENS-JOHNSON SYNDROME 448 0.0201
866 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 1433 0.0201
867 ABNORMAL BEHAVIOUR 795 0.0200
868 INJECTION SITE HAEMATOMA 290 0.0200
869 PRODUCT PHYSICAL ISSUE 403 0.0200
870 DEVICE OCCLUSION 281 0.0199
871 PRODUCT DOSE OMISSION 1296 0.0198
872 LUNG NEOPLASM MALIGNANT 814 0.0198
873 PRODUCT USE COMPLAINT 311 0.0197
874 THERAPY CESSATION 1009 0.0196
875 THERAPY NON-RESPONDER 881 0.0196
876 THERAPY INTERRUPTED 1394 0.0195
877 URTICARIA 3245 0.0194
878 DRUG ADMINISTRATION ERROR 591 0.0192
879 DEVICE RELATED INFECTION 296 0.0192
880 MUCOSAL INFLAMMATION 503 0.0192
881 IRRITABILITY 1145 0.0190
882 DRUG EFFECT LESS THAN EXPECTED 282 0.0190
883 ANGER 642 0.0190
884 PSYCHOTIC DISORDER 560 0.0189
885 SYNOVITIS 341 0.0189
886 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 3389 0.0188
887 PRODUCT DOSE OMISSION ISSUE 5492 0.0187
888 INCORRECT DRUG ADMINISTRATION DURATION 525 0.0186
889 MULTIPLE FRACTURES 304 0.0185
890 PLASMA CELL MYELOMA 719 0.0184
891 INTENTIONAL DRUG MISUSE 385 0.0184
892 ILL-DEFINED DISORDER 1118 0.0184
893 SUICIDAL IDEATION 1679 0.0183
894 OFF LABEL USE 16038 0.0183
895 ANAPHYLACTIC REACTION 1011 0.0183
896 PSYCHOMOTOR HYPERACTIVITY 303 0.0182
897 DRUG DOSE OMISSION 3006 0.0182
898 NEUTROPHIL COUNT DECREASED 738 0.0181
899 ADVERSE DRUG REACTION 1626 0.0181
900 COMPLETED SUICIDE 1508 0.0181
901 SURGERY 1052 0.0179
902 EMOTIONAL DISORDER 552 0.0179
903 CRYING 648 0.0178
904 DISEASE PROGRESSION 2097 0.0177
905 DRUG EFFECT DECREASED 953 0.0177
906 NERVOUS SYSTEM DISORDER 542 0.0173
907 DRUG INEFFECTIVE 22726 0.0172
908 PRODUCT QUALITY ISSUE 2330 0.0171
909 NEUTROPENIA 2324 0.0171
910 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 398 0.0171
911 PRODUCT USE ISSUE 3207 0.0170
912 THERAPEUTIC RESPONSE DECREASED 1029 0.0170
913 PRODUCT USE IN UNAPPROVED INDICATION 4195 0.0169
914 DRUG EFFECT INCOMPLETE 614 0.0169
915 TOXICITY TO VARIOUS AGENTS 2846 0.0169
916 RESPIRATORY ARREST 464 0.0168
917 EPILEPSY 510 0.0167
918 AGRANULOCYTOSIS 305 0.0164
919 DISABILITY 323 0.0163
920 ANAPHYLACTIC SHOCK 414 0.0160
921 THERAPEUTIC RESPONSE SHORTENED 530 0.0160
922 EMOTIONAL DISTRESS 1922 0.0159
923 SEIZURE 1832 0.0158
924 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 408 0.0158
925 ADVERSE EVENT 1458 0.0158
926 INJECTION SITE MASS 583 0.0157
927 TOOTH LOSS 326 0.0157
928 PRODUCT AVAILABILITY ISSUE 357 0.0157
929 PELVIC PAIN 284 0.0156
930 EXPIRED PRODUCT ADMINISTERED 510 0.0153
931 NEOPLASM MALIGNANT 1021 0.0153
932 PERITONITIS 315 0.0152
933 INCORRECT DOSE ADMINISTERED 3460 0.0151
934 MULTIPLE SCLEROSIS 723 0.0151
935 NEEDLE ISSUE 438 0.0150
936 INCORRECT PRODUCT ADMINISTRATION DURATION 321 0.0148
937 UNDERDOSE 1080 0.0148
938 MOOD SWINGS 471 0.0148
939 MALIGNANT NEOPLASM PROGRESSION 1496 0.0146
940 SYSTEMIC LUPUS ERYTHEMATOSUS 511 0.0144
941 INJECTION SITE HAEMORRHAGE 1138 0.0142
942 HOSPITALISATION 2172 0.0141
943 INJECTION SITE PRURITUS 945 0.0141
944 NEOPLASM PROGRESSION 488 0.0140
945 THERAPEUTIC PRODUCT EFFECT DECREASED 628 0.0140
946 DEATH 11915 0.0138
947 APPLICATION SITE ERYTHEMA 360 0.0137
948 PANCREATIC CARCINOMA 396 0.0137
949 APPLICATION SITE PRURITUS 309 0.0136
950 WITHDRAWAL SYNDROME 567 0.0135
951 SUICIDE ATTEMPT 816 0.0134
952 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 733 0.0133
953 INJECTION SITE PAIN 4090 0.0133
954 PRODUCT DISPENSING ERROR 286 0.0131
955 OSTEONECROSIS 431 0.0131
956 GYNAECOMASTIA 405 0.0131
957 INTENTIONAL OVERDOSE 834 0.0130
958 PRODUCT PRESCRIBING ISSUE 283 0.0130
959 MULTIPLE SCLEROSIS RELAPSE 887 0.0129
960 INJECTION SITE BRUISING 1027 0.0129
961 BONE DENSITY DECREASED 402 0.0128
962 SKIN BURNING SENSATION 903 0.0126
963 TARDIVE DYSKINESIA 353 0.0125
964 INJECTION SITE RASH 383 0.0125
965 INJECTION SITE ERYTHEMA 1530 0.0123
966 DEVICE MALFUNCTION 863 0.0123
967 OVERDOSE 2589 0.0120
968 EXTRAPYRAMIDAL DISORDER 296 0.0119
969 DERMATITIS ATOPIC 608 0.0115
970 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 2325 0.0115
971 INJECTION SITE SWELLING 865 0.0113
972 BREAST CANCER FEMALE 284 0.0106
973 EXTRA DOSE ADMINISTERED 427 0.0105
974 DEVICE ISSUE 928 0.0103
975 SKIN IRRITATION 473 0.0103
976 PROSTATE CANCER 825 0.0102
977 INJECTION SITE REACTION 648 0.0094
978 BREAST CANCER 858 0.0092
979 DEVICE DISLOCATION 396 0.0091
980 VAGINAL HAEMORRHAGE 390 0.0090
981 PRODUCT ADHESION ISSUE 308 0.0086
982 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 281 0.0083
983 ACNE 630 0.0083
984 TREATMENT FAILURE 676 0.0082
985 BLADDER CANCER 477 0.0081
986 DEVICE LEAKAGE 344 0.0079
987 NO ADVERSE EVENT 1293 0.0071
988 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 330 0.0071
989 DRUG WITHDRAWAL SYNDROME 613 0.0070
990 ACCIDENTAL EXPOSURE TO PRODUCT 670 0.0065
991 DRUG ABUSE 475 0.0057
992 PRODUCT STORAGE ERROR 468 0.0053
993 DRUG DOSE OMISSION BY DEVICE 302 0.0039
994 DRUG DEPENDENCE 564 0.0035